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Introduction and Hypothesis:  58 
There is a difference of opinion in the literature as to whether or not pelvic organ 59 
prolapse (POP) is a direct cause of FSD. Sexual function in women is negatively 60 
impacted by presence of urinary symptoms. Sexual dysfunction(SD) might be 61 
improved, unchanged or worsened by pelvic floor surgery. 62 
Methods: 63 
In this study we observed the SD and impact of surgical intervention on female 64 
sexual function using validated questionnaire (PISQ-12) in women undergoing pelvic 65 
organ prolapse +/- urinary incontinence surgery. 200 women were recruited and 66 
followed up 6 and 12 months post operatively. 67 
Results: 68 
Sexual function as measured by the PISQ-12 improved after surgery irrespective of 69 
the nature of surgery or the patient’s past gynaecology history. Improvement in 70 
sexual function was seen by 6 months (97 patients) post-surgery (p <0.05) after 71 
which(assessed at 12 months – 80 patients)  no further change in PISQ-12 was 72 
observed. Improved sexual function was associated with better patient satisfaction 73 
post-operatively. 74 
Conclusions:  75 
Sexual function improved after surgery irrespective of nature of surgery and patient 76 
past gynaecology history. Our study will help in counselling women with POP and/or 77 
UI undergoing surgery about potential improvement in sexual function. 78 
.  79 
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Summary: Majority of women will have improvement in sexual function after  81 
prolapse +/- incontinence surgery and this is strongly positively associated with 82 

















Female Sexual Dysfunction (FSD) is a common problem, with data from the National 99 
Health and Social Life Survey showing that 43% of women aged 18–59 years 100 
experiencing some form of FSD(1). The aetiology of FSD is multifactorial, with 101 
hormonal, psychological, anatomical, vascular and neurogenic elements all being 102 
possible aetiological factors(2).  103 
Pelvic Organ Prolapse (POP) and urinary incontinence (UI) form a major health 104 
burden to women affecting 41-65% of women. Large population study suggests that 105 
the prevalence of stage three or four prolapse is in the range of 2-11% (3,4). An 106 
epidemiological study reported UI to affect up to 41% of the women. (5). At least 1 in 107 
3 parous women undergo at least one surgery for these conditions by the age of 80 108 
years (6). Women with POP and /or UI are at higher risk of sexual dysfunction (7, 8, 109 
9,10,11) compared to those without. 110 
Traditionally pelvic floor surgeons have assessed the outcome of vaginal repair 111 
surgery by the degree of restoration of normal pelvic anatomy. Increasingly, however 112 
the effect of prolapse surgery upon a woman’s sexual function is being used as an 113 
outcome measure of the success of surgical repair (12,13), especially since the 114 
introduction of vaginal mesh repairs for prolapse (14). 115 
There is a difference of opinion in the literature however as to whether or not Pelvic 116 
Organ Prolapse (POP) is a direct cause of FSD. It may not be the prolapse itself but 117 
rather the associated coital incontinence that predicts sexual dysfunction. Likewise, it 118 
appears that vaginal anatomy per se is not an independent factor in the aetiology of 119 
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FSD: neither vaginal calibre, nor length, nor atrophy, nor menopausal status have a 120 
direct influence on the presence of FSD(22).  121 
AIMS  122 
In this study we aimed to assess the incidence of FSD in a group of sexually active 123 
women with stress urinary incontinence (SUI) and/or pelvic organ prolapse (POP) 124 
awaiting surgical management. The secondary aim was to determine whether 125 
vaginal surgery for prolapse or UI leads to alteration in sexual function and to 126 
compare SF in subjects undergoing POP or UI surgery alone with POP surgery 127 
combined with UI surgery. 128 
STUDY POPULATION 129 
The study was co-ordinated from the Department of Urogynaecology at the South 130 
Glasgow University Hospital in their established Urogynaecology and Pelvic Floor 131 
Dysfunction Research Unit.  All women undergoing any type of POP repair and/ or 132 
urinary incontinence surgery were invited to participate in the study.  200 women 133 
were recruited through the Urogynaecology clinics across the service over a 12-134 
month period from June 2011 to May 2012. All women gave written informed 135 
consent to be involved in the study. 136 
FUNDING 137 
Project was funded by the Department of Urogynaecology, South Glasgow 138 
University Hospital.  139 
INCLUSION CRITERIA 140 
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1. Women on the waiting list for surgical repair of POP, UI procedure or both, 141 
and; 142 
2. Who have been sexually active in the last 6 months and expect to remain so 143 
post-operatively, or;  144 
EXCLUSION CRITERIA 145 
1. Women under 18 years of age 146 
2. Women unable to understand information leaflet  147 
3. Women unable to complete the questionnaire 148 
DATA COLLECTION 149 
Patient’s demographics and details about their surgical procedure(s) were obtained 150 
from the patient’s hospital records.  151 
 152 
METHODOLOGY 153 
This was a prospective observational study. Ethical approval was obtained from 154 
West of Scotland Ethics Committee. Reference number: 10/S0709/69; 16/03/2011. 155 
Women complaining of symptomatic pelvic organ prolapse and/or SUI who were on 156 
the waiting list for pelvic prolapse surgery (POP) +/- urinary incontinence (UI) surgery 157 
were recruited at preoperative assessment visit or during hospital admission for their 158 
procedure. Consenting participants completed the preoperative questionnaire which 159 
included primary and secondary outcome measures prior to surgery.  160 
At 6 and 12 months after surgery a further set of questionnaire(baseline 161 
questionnaire and a self designed questionnaire appendix 1) was sent to women by 162 
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post, along with a stamped addressed envelope, to be completed at home and 163 
returned. Women who did not respond within 2 weeks were sent a reminder letter 164 
and questionnaire, and then they were contacted by telephone if there was no 165 
response after a further 2 weeks. 166 
Primary outcome 167 
Primary Outcome was to assess incidence of sexual dysfunction by condition 168 
specific validated quality of life assessment tool Prolapse/urinary incontinence sexual 169 
questionnaire short form (PISQ 12) score. (Rogers 2001, 2003)  170 
Secondary outcomes 171 
Secondary outcome was the change in PISQ-12 and International consultation on 172 
Incontinence Questionnaire – Vaginal Symptoms (ICIQ-VS) between baseline and 6 173 
and 12 months after surgery. We also assessed urinary incontinence symptom 174 
distress and its life impact at 6 and 12 months using urogenital distress inventory 175 
short form (UDI-6) and Incontinence Impact Questionnaire IIQ-7. Patient satisfaction 176 
with surgery was measured using a study specific , non validated instrument 177 
(appendix 1) at 6 and 12 months.  178 
Analysis 179 
We tabulated descriptive statistics, reporting baseline demographics and clinical 180 
characteristics with means and SDs, or medians and IQRs as appropriate. A paired 181 
t-test was used to compare baseline, 6 month and 12 month scores, and analysis of 182 
variance to test for differences between surgery groups and post operative 183 
satisfaction levels.  Data were analysed in SPSS version 19 and a 5% level of 184 




Two hundred women were recruited of which 180 (90%) returned completed 188 
baseline questionnaires. At 6-months 97 (48.5%) patients returned completed 189 
questionnaires. 87 (43.5%) questionnaires were returned completed at 12-months 190 
(Figure 1). 191 
The mean age of participants was 54.4 years (SD 10.1). All women except 3 were 192 
parous with a median parity of 2 (range 0-5). 121 (67.2%) women were post-193 
menopausal out of which 15 (8.3%) were on HRT at the time of their surgery.  A 194 
significantly higher proportion of women who had surgery for prolapse were 195 
menopausal (Chi-square = 9.412, df = 2, P = 0.009). The majority of women who had 196 
surgery for POP (98%) had stage II or greater prolapse (Table 1). 197 
Thirty-seven (19.5%) women had POP surgery in the past, of which the majority had 198 
conventional prolapse surgery without the use of mesh. Four (2.2 %) patients had 199 
surgery using mesh graft and 2 (1.1%) had both conventional and surgery using 200 
mesh. Seventeen (9.5%) patients had a previous UI procedure. One hundred and 201 
sixteen (68%) patients had no documented urinary symptoms (table 1). 202 
A total of 130 women underwent POP surgery, 29 had UI surgery and 21 women 203 
had both POP and UI surgery (Table 2). 204 
Sexual function 205 
Overall the mean baseline PISQ-12 score in our study population was 30.54 (SD 206 
6.55). There was no statistical difference in baseline PISQ-12 in women as per their 207 
age, parity, menopausal status or whether they had previous POP and /or UI 208 
surgery(table 3). There was also no statistically significant difference in the baseline 209 
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PISQ-12 between groups of women awaiting only POP surgery or only UI surgery or 210 
both POP and UI surgery (Table 4). 211 
For all women the mean PISQ-12 score increased (improved) to 33.4 (SD 7.36) at 6 212 
months and 33.5 (SD 7.40) at 12 months (Table 3). The improvement in PISQ-12 213 
score from baseline to 6 and 12 months was statistically significant (Table 3) but not 214 
from 6 months to 12 months.  The improvement in PISQ-12 was not significantly 215 
different between the groups of women having POP surgery,  UI  surgery  or  both  216 
POP  and  UI  surgery (ANOVA F=2.266,  df=2,  p=0.109). It was also not influenced 217 
by any of the above mentioned demographic characteristics.  218 
Improvements in UDI-6, VS and IIQ-7 scores from baseline to 6 months were 219 
statistically significant but not from 6 to 12 months, similar to PISQ-12 scores (Table 220 
4). 221 
No significant difference was seen between surgery types (no mesh, vaginal mesh 222 
for prolapse, mesh for UI, abdominal mesh for prolapse) in the change in PISQ-12 223 
score from baseline to 6 months (ANOVA F = 1.463, df=3, p=0.230), specifically 224 
there was no difference between women having prolapse surgery with and without 225 
mesh (mean difference -0.99, standard error 1.49, p=0.510). 226 
Other outcomes 227 
Improvement in UDI-6 and IIQ-7 scores from baseline to 6 months was significantly 228 
different between the three surgery groups (ANOVA F = 15.9, df = 2, P<0.005 and  F 229 
= 17.9, df = 2, p < 0.005 respectively). There was significantly more improvement  in 230 
both UDI and IIQ scores for those women who had prolapse surgery alone 231 
compared to those women who had UI surgery only or those who had combined UI 232 
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and prolapse surgery. Improvement in VS scores from baseline to 6 months was not 233 
significantly different between groups (ANOVA F = 1.757, df = 2, p = 0.178).  234 
Relationship with patient satisfaction 235 
Seventy-seven (83%) women at 6 months and 60 (78%) women at 1 year reported 236 
being either satisfied or very satisfied with their surgical outcome. Being satisfied 237 
with surgery at 6 months (not satisfied / satisfied / very satisfied) was significantly 238 
associated with improvement in PISQ-12 score from baseline to 6-months (ANOVA 239 
F=5.915, df =2, p=0.004). 240 
Improvements in UDI-6 (ANOVA F= 4.293, df =2, p=0.017) and VS scores (ANOVA 241 
F= 3.771, df = 2, p=0.025) at 6 months from baseline were also statistically 242 
significantly associated with patient satisfaction, however improvement in IIQ-7 was 243 
not (ANOVA F = 1.618, df = 2, p = 0.204). 244 
Discussion 245 
Surgery for prolapse has a role in reconstructing the local anatomy and alleviating 246 
some symptoms but does not necessarily ensure optimal sexual function. Sexual 247 
function might be improved (15, 16, 17), remains unchanged (8, 18) or worsened 248 
(19) after repair. Improvement in sexual function could also be due to emotional 249 
amelioration due to the cessation of incontinence (20, 21). 250 
Most papers however only report on sexual function as a secondary finding. Most 251 
are retrospective in nature, and only a few have involved the use of a validated 252 
sexual function questionnaire (22). The prospective studies are either small with 3- 6 253 
months follow up (8) or have used non condition specific questionnaires. Our study 254 
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has large numbers with 1-year follow-up and we have used a validated condition 255 
specific SF questionnaire with SF as the primary outcome. 256 
Previously several retrospective and prospective studies have used either non 257 
validated SF questionnaires (8, 17) or self designed questionnaire or telephonic 258 
conversation. Recently condition specific validated sexual health questionnaires 259 
have been developed. At start of this trial the PISQ-31(Pelvic organ prolapse 260 
/Urinary incontinence Sexual Function Questionnaire) (including the short form 261 
PISQ-12) was the only validated condition specific (prolapse and UI) female sexual 262 
function questionnaire available. Other validated condition specific questionnaire that 263 
have been used to assess sexual function following pelvic floor surgery (e.g. Kings 264 
Health Questionnaire, ICIQ-VS) are quality of life questionnaires which include few 265 
questions addressing SF, they really deal with the overall impact of POP and/or UI 266 
surgery on the patients QoL. We therefore chose to use (the short form) PISQ-12 267 
questionnaire for our study. However, we appreciate that this questionnaire only 268 
discriminates between women with and with out sexual dysfunction within the group 269 
of women with POP and UI and may not be optimal to detect SD following treatment 270 
as also concluded by Roos et al 2014 (23). We also understand that PISQ 271 
represents the positive effects of surgery well but does not reflect the possible 272 
negative effects of surgery on sexual function (16). 273 
In our study population the mean PISQ-12 score was 30.54 (SD 6.55) with the 274 
maximum possible score of 48. Although a range of score for this instrument (PISQ 275 
12) has not yet been established to classify severity of sexual dysfunction, we 276 
believe that our findings indicate that women enrolled in our study displayed a 277 
significant decrement in SF before POP and/or UI surgery. This observation is 278 
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consistent with several prior studies that found reduced SF in women with UI and/or 279 
POP or both (24,25,26). 280 
The baseline PISQ-12 appears to be comparable to that reported by Brubaker in 281 
SISTEr Trial 2009 (mean 30.54) but lower than that reported by Glavind et al  (mean 282 
35.3) (27). This might be due to different baseline characteristics or different 283 
population. 284 
We found statistically significant improvement in PISQ 12 score from baseline 285 
(30.54) to 6 months (33.45). Other studies which have reported statistical significant 286 
improvement in the score from baseline either have much smaller number of patients 287 
and shorter follow up.  288 
In two different prospective study by Glavind et al (27) with short term follow up after 289 
prolapse surgery (n=81) reported baseline PISQ12 of 35.2 with postop improvement  290 
with positive difference of 3.0 (SD 3.8).  Brubaker also reported significant 291 
improvement in PISQ-12 scores from 31.6 (SD 6.85) to 36.85 (SD 5.89). In a long 292 
term study by Lindquist et all where 63 patients after tension free vaginal tapes were 293 
followed for 4 years (n=44 ) used PISQ12 and quoted baseline mean PISQ12 of 33.8 294 
which improved postoperatively(28). 295 
Another prospective study by Thakar et al (16), in which 46 women were followed for 296 
4 months post surgery showed significant improvement in SF after surgery for POP 297 
and UI at 4 months. Srikrishna et al (17) recruited 52 sexually active women and 298 
followed them up for 2 years using the GRISS and KHQ questionnaires, concluding 299 
that SF improved following surgery for POP with or out UI procedure. The results of 300 
the above two studies are not comparable as they used different questionnaires. 301 
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In a study by Paul et al (8) where 51 patients followed for 6 months, found that SF as 302 
measured by FSFI and sexual frequency were unchanged following vaginal surgery 303 
for pelvic organ prolapse with or without UI surgery, despite improvement in the 304 
stage of prolapse and incontinence symptoms. Weber et al 2005 reported that SF 305 
and satisfaction improved or did not change in most women after surgery for 306 
prolapse and /or UI. Rogers et al (15) reported mixed results with improved SF in 68 307 
% of women and worsened function in 32% using 2 validated, condition specific 308 
questionnaire (PISQ-12 and IIQ-7) preoperatively and 3 and 6 months after surgery 309 
in 102 women with a mean age of 47 years. Similar to our study they observed no 310 
differences in the total SF scores between women who underwent POP and UI 311 
surgery and those who had only UI or only POP surgery. 312 
We found statistically significant improvement in PISQ-12 score from baseline to 6 313 
months with a positive score of 2.91. The minimum clinically important difference for 314 
the PISQ-12 is not yet determined. We observed positive improvement in SF scores 315 
by PISQ-12. Sloan et al proposed that a change of greater than half of the SD of the 316 
pre intervention score is a conservative estimate of an effect size that is clinically 317 
meaningful when using QOL questionnaires. (29).  318 
We observed no further improvement in PISQ-12 score after 6 months. This 319 
suggests that any improvement in SF due to surgery is generally seen within the first 320 
6-months; however the effect does appear to be maintained up to 1-year. Other 321 
studies using self designed non-validated questionnaire or much smaller numbers 322 
(15) have shown stability in SF outcomes over follow up period. We therefore 323 
suggest following this and our findings that assessment at 6 or 12 months are 324 
unlikely to be significantly different and the 6 month follow up can be used for 325 
comparison.  326 
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Success of surgery was defined as patient satisfaction. In our study improvement in 327 
PISQ-12 was observed in women with successful surgery and hence associated with 328 
patient satisfaction postoperatively. This was seen in all three subgroups.  329 
Improvement in SF was strongly influenced by the outcome of surgery i.e. patient 330 
satisfaction. Patient who were satisfied with their surgical outcome reported 331 
improvement in PISQ-12 score compared to those who were not either because of 332 
failure in improvement of symptom or new onset symptom like SUI following POP 333 
surgery. Patient who reported improvement in UDI 6 and VS scores also reported 334 
high satisfaction with their surgical outcome. It may be the presence or absence of 335 
Urinary symptoms rather than surgical technique which defines sexual function (26). 336 
 337 
 The numbers in each subgroup of surgery type were too small to make any 338 
comment on whether one technique/surgery improves SF more than the others. In 339 
our study we saw significant improvement in all groups of women with or without 340 
incontinent and hence can conclude that SF improves after surgery not only due to 341 
improvement in UI scores but also due to amelioration in symptoms due to POP. 342 
In our study we found significant improvement in UDI and IIQ 7 in the POP only 343 
group where no UI surgery was performed and also significant improvement in VS 344 
score in the UI only group where no prolapse surgery was performed. This may have 345 
contributed to improvement in the PISQ-12 score post operatively in both the POP 346 
only and UI only groups (27). In a cohort of 1267 sexually active women Tok et al 347 
(30) found that women with prolapse had lower SF scores than those without the 348 
POP due to fear of UI during intercourse and also avoidance of sexual intercourse 349 
due to POP. It is therefore understandable that correcting the POP and improving 350 
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the body image and ameliorating the symptoms should lead to improvement in the 351 
SF. 352 
We found improvement in PISQ-12 post operatively irrespective of technique or type 353 
of surgery performed for UI. Improvement in UI scores/symptoms was associated 354 
with patient satisfaction. Whilst our cohort size may have been too small to look for 355 
differences in surgical techniques, our findings are consistent with other authors. 356 
Brubaker 2009(26) (SISTEr trial) concluded SF improves after successful surgery for 357 
UI and was irrespective of type/technique of UI surgery and also stage of pop or 358 
with/out concomitant POP surgery. 359 
Our study has lots of strength. It is a prospective study with a large number of 360 
patients. We have used a disease specific validated questionnaire PISQ-12. We 361 
have followed up our patients for 1 year postoperatively and have used multiple 362 
validated indices of bladder, POP and sexual function 363 
We acknowledge the limitations to our study. There is no normative data for PISQ-12 364 
established and questionnaire only demonstrates the effect of intervention (10). As 365 
this is only an observational study it is not possible to have a definite conclusion that 366 
it was the intervention that led to improvement. Degree of distress cannot be 367 
established as condition specific questionnaire measuring distress is not available at 368 
present (16). Sexual questionnaire IUGA Revised (PISQ-12 R) was not used as this 369 
was not available at the time when study was performed 370 
The presence of POP and /or UI rather than severity of the problem or subtype of 371 
POP may impact SF. We did not do any objective follow up for prolapse so are 372 
unable to comment if improvement in sexual function as reported by patients is due 373 
to functional improvement rather than secondary to objective improvement in UI and 374 
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/or POP (31). Srikrishna et al (17) objectively assess women at follow up and found 375 
that the women with better supported pelvic floor were less likely to have sexual 376 
dysfunction. 377 
We however instead used validated IIQ7 and VS questionnaires which evaluate the 378 
impact of POP and UI on social function. This may not exactly represent objective 379 
evidence of cure of UI and POP however, they do assess in a standardised and 380 
validated way the patient’s overall improvement and perception of success of 381 
surgery. Thus IIQ7 and VS scores are relevant to study for sexual function after 382 
treatment of UI and or POP and are representative of successful treatment of POP 383 
and or UI surgery (15). 384 
We also acknowledge that there were women who did not complete the forms at 385 
recruitment and follow up as they found it too embarrassing. However, our remaining 386 




Sexual function improves after surgery for POP and UI in the majority of patients. 391 
This improvement is strongly positively associated with patient satisfaction with the 392 
surgery. Improvement is seen by 6 months and tends to be maintained at 1-year. 393 
 394 
Our study will help in counselling women with POP and/or UI undergoing surgery 395 





1. Laumann EO, Paik A, Rosen RC Sexual dysfunction in the United States: 400 
prevalence and predictors JAMA 1999 281 537–44 401 
doi:10.1001/jama.281.6.537. 402 
2. Fertility and Sterility403 
dysfunction: classification,pathophysiology, and management  Rupesh Raina, 404 
M.D.,Geetu Pahlajani, M.D.,Shazia Khan, M.D.,Sajal Gupta, M.D., Ashok 405 
Agarwal, Ph.D.,and Craig D. Zippe, M.D. 406 
3. Swift SE (2000) .(2000) Distribution of pelvic organ support in a population of female 407 
subjects seen for routine gynaecological health care. Am J Obstet Gynecol. 2000 408 
Aug;183(2):277-85. 409 
4. Swift S, Woodman P, O'Boyle A, Kahn M, Valley M, Bland D, Wang W, Schaffer J 410 
(2005) Pelvic Organ Support Study (POSST): the distribution, clinical definition, and 411 
epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005 412 
Mar;192(3):795-806. 413 
5. Jolleys JV (1988) Reported prevalence of urinary incontinence in women in a general 414 
practice. Br Med J (Clin Res Ed). 1988 May 7;296(6632):1300-2. 415 
6. Fialkow MF, Newton KM, Lentz GM, Weiss NS (2008) Lifetime risk of surgical 416 
management for pelvic organ prolapse or urinary incontinence..Int Urogynecol J 417 
Pelvic Floor Dysfunct. 2008 Mar;19(3):437-40. Epub 2007 Sep 26.  418 
7. Barber MD, Visco AG, Wyman JF, Fantl JA, Bump RC; Continence Program for 419 
Women Research Group (2002) Sexual function in women with urinary incontinence 420 
and pelvic organ prolapse. Obstet Gynecol. 2002 Feb;99(2):281-9 421 
 20 
8. Pauls RN, Silva WA, Rooney CM, Siddighi S, Kleeman SD, Dryfhout V, Karram MM 422 
(2007) Sexual function after vaginal surgery for pelvic organ prolapse and urinary 423 
incontinence.. Am J Obstet Gynecol. 2007 Dec;197(6):622.e1-7. 424 
9. Salonia A, Zanni G, Nappi RE, Briganti A, Dehò F, Fabbri F, Colombo R, Guazzoni 425 
G, Di Girolamo V, Rigatti P, Montorsi F (2004) Sexual dysfunction is common in 426 
women with lower urinary tract symptoms and urinary incontinence: results of a 427 
cross-sectional study. Eur Urol. 2004 May;45(5):642-8; discussion 648  428 
10. Rogers RG, Kammerer-Doak D, Villarreal A, et al. (2001) A new instrument to 429 
measure sexual function in women with urinary incontinence or pelvic organ 430 
prolapse. Am J Obstet Gynecol 2001; 184:552 431 
11. Handa VL, Cundiff G, Chang HH, Helzlsouer KJ (2008) Female sexual function and 432 
pelvic floor disorders.. Obstet Gynecol. 2008 May;111(5):1045-52. doi: 433 
10.1097/AOG.0b013e31816bbe85 434 
12. Nappi R, Salonia A, Traish AM, van Lunsen RH, Vardi Y, Kodiglu A, Goldstein I. 435 
(2005) Clinical biologic pathophysiologies of women's sexual dysfunction. J Sex Med. 436 
2005 Jan;2(1):4-25 437 
13. Althof SE, Dean J, Derogatis LR, Rosen RC, Sisson M (2005) Current Perspectives 438 
on the Clinical Assessment and Diagnosis of Female Sexual Dysfunction and Clinical 439 
Studies of Potential Therapies: A Statement of Concern. J Sex Med 2005;48:642-9  440 
14. Su TH, Lau HH, Huang WC, Chen SS, Lin TY, Hsieh CH, Yeh CY. (2009) Short term 441 
impact on female sexual function of pelvic floor reconstruction with the Prolift 442 
procedure. J Sex Med. 2009 Nov;6(11):3201-7. doi: 10.1111/j.1743-443 
6109.2009.01399.x. Epub 2009 Jul 21 444 
15. Rogers RG, Kammerer-Doak D, Darrow A, Murray K, Qualls C, Olsen A, Barber M 445 
(2006) Does sexual function change after surgery for stress urinary incontinence 446 
 21 
and/or pelvic organ prolapse? A multicenter prospective study. Am J Obstet Gynecol 447 
195(5):e1–e4 448 
16. Thakar R, Chawla S, Scheer I, et al. (2008) Sexual function following pelvic floor 449 
surgery. Int J Gynaecol Obstet 2008; 102:110. 450 
17. Srikrishna S, Robinson D, Cardozo L, Gonzalez J. (2010) Can sex survive pelvic 451 
floor surgery? Int Urogynecol J. 2010 Nov;21(11):1313-9. doi: 10.1007/s00192-010-452 
1198-x. Epub 2010 Jun 25.  453 
18. Occhino JA, Trabuco EC, Heisler CA, Klingele CJ, Gebhart JB. (2011) Changes in 454 
vaginal anatomy and sexual function after vaginal surgery. Int Urogynecol J. 2011 455 
Jul;22(7):799-804. doi: 10.1007/s00192-011-1386-3. Epub 2011 Mar 17 456 
19. Helström L, Nilsson B  (2005) Impact of vaginal surgery on sexuality and quality of 457 
life in women with urinary incontinence or genital descensus. Acta Obstet Gynecol 458 
Scand. 2005 Jan;84(1):79-84. 459 
20. Hasse P, Skidstead ,L (1988) Influence of operations for stress incontinence and/or 460 
genital descensus on sexual life. Acta Obstet Gynecol Scand, 1988;67(7):659-61 461 
21. Lemack G E, Zimmern P E (2000) Sexual function after vaginal surgery for stress 462 
incontinence: results of a mailed questionnaire. Urology, 56: 223, 2000 463 
22. Neill C., Abdel-Fattah M, Ramsay I N (2009), Sexual function and vaginal surgery. 464 
The Obstetrician & Gynaecologist, 11: 193–198. doi:10.1576/toag.11.3.193.27504 465 
23. Roos AM, Thakar R, Sultan AH, de Leeuw JW, Paulus AT (2014) The impact of 466 
pelvic floor surgery on female sexual function: a mixed quantitative and qualitative 467 
study.. BJOG. 2014 Jan;121(1):92-100; discussion 101. doi: 10.1111/1471-468 
0528.12412. Epub 2013 Sep 10 469 
 22 
24. Barber MD, Visco AG, Wyman JF, Fantl JA, Bump RC; Continence Program for 470 
Women Research Group (2002) Sexual function in women with urinary incontinence 471 
and pelvic organ prolapse..Obstet Gynecol. 2002 Feb;99(2):281-9. 472 
25. Weber AM, Walters MD, Schover LR, Mitchinson A. (1995) Sexual function in women 473 
with uterovaginal prolapse and urinary incontinence. Obstet Gynecol 1995; 85:483. 474 
26. Brubaker L, Chiang S, Zyczynski H, Norton P, Kalinoski DL, Stoddard A, Kusek JW, 475 
Steers W  Urinary Incontinence Treatment Network. The impact of stress 476 
incontinence surgery on female sexual function.;. Am J Obstet Gynecol. 2009 477 
May;200(5):562.e1-7. doi: 10.1016/j.ajog.2008.11.017. Epub 2009 Mar 16 478 
27. Glavind K,  Sexual function in women before and after surgery for pelvic organ 479 
prolapse.  AOGS 2015; 94: 80-85 Int Urogynecol J. 2016 Oct;27(10):1571-6. 480 
doi: 10.1007/s00192-016-3004-x. Epub 2016 Mar 18. 481 
28. Lindquist AS, Glavind K Long-term follow-up of sexual function in women 482 
before and after tension-free vaginal tape operation for stress urinary 483 
incontinence. IUJ 2016: 27: 1571-76 484 
29. Sloan J, Symonds T, Vargas-Chanes D, Fridley B: Practical Guidelines for Assessing 485 
the Clinical Significance of Health-Related Quality of Life Changes within Clinical 486 
Trials. Drug Information Journal 2003,37(1):23–31 487 
30. Tok EC1, Yasa O, Ertunc D, Savas A, Durukan H, Kanik A.(2010) The effect of pelvic 488 
organ prolapse on sexual function in a general cohort of women. J Sex Med. 2010 489 
Dec;7(12):3957-62. doi: 10.1111/j.1743-6109.2010.01940.x. 490 
31. Lowenstein L, Gamble T, Sanses TV, et al. (2010) Changes in sexual function after 491 
treatment for prolapse are related to the improvement in body image perception. J 492 




















Appendix 1 512 
 24 
Department of Urogynaecology   
Southern General Hospital 
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PATIENT SATISFACTION QUESTIONNAIRE 
 
1. How satisfied are you with your surgery? 
 
 Not satisfied 
 Equivocal 
 Satisfied 
 Very satisfied 
 




 Bleeding requiring hospital attendance/admission 
 Mesh erosion 
 Others 
 
3. How much do you think your symptoms have resolved? 
 1            2            3          4         5         6       7         8        9       10 
Not resolved                                                                completely resolved 
 
 
4. Have you needed any further surgery for your symptoms? 
 No 
 Yes ……please specify…………… 
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